Form 8-K - Current report:
SEC Accession No. 0001558370-24-000603
Filing Date
2024-01-29
Accepted
2024-01-29 08:40:14
Documents
18
Period of Report
2024-01-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20240123x8k.htm   iXBRL 8-K 39820
2 EX-10.1 cydy-20240123xex10d1.htm EX-10.1 74563
3 EX-99.1 cydy-20240123xex99d1.htm EX-99.1 15561
4 GRAPHIC cydy-20240123xex99d1001.jpg GRAPHIC 5423
  Complete submission text file 0001558370-24-000603.txt   361578

Data Files

Seq Description Document Type Size
5 EX-101.SCH cydy-20240123.xsd EX-101.SCH 3249
6 EX-101.LAB cydy-20240123_lab.xml EX-101.LAB 634
7 EX-101.PRE cydy-20240123_pre.xml EX-101.PRE 9554
19 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20240123x8k_htm.xml XML 4303
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 24570549
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)